These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9818622)

  • 1. Introduction. Reboxetine: a new selective antidepressant for the treatment of depression.
    Montgomery SA; Schatzberg AF
    J Clin Psychiatry; 1998; 59 Suppl 14():3. PubMed ID: 9818622
    [No Abstract]   [Full Text] [Related]  

  • 2. Reboxetine--another new antidepressant.
    Drug Ther Bull; 1998 Nov; 36(11):86-8. PubMed ID: 10562766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressant efficacy and tolerability of the selective norepinephrine reuptake inhibitor reboxetine: a review.
    Burrows GD; Maguire KP; Norman TR
    J Clin Psychiatry; 1998; 59 Suppl 14():4-7. PubMed ID: 9818623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of norepinephrine in the treatment of depression.
    J Clin Psychiatry; 1999 Sep; 60(9):623-31. PubMed ID: 10520985
    [No Abstract]   [Full Text] [Related]  

  • 5. Novel antidepressant strategies to optimize outcome.
    J Clin Psychiatry; 2000 Sep; 61(9):686-96. PubMed ID: 11030494
    [No Abstract]   [Full Text] [Related]  

  • 6. Introduction. Norepinephrine: neurotransmitter for the millennium.
    Nemeroff CB
    J Clin Psychiatry; 2000; 61 Suppl 10():3-4. PubMed ID: 10910011
    [No Abstract]   [Full Text] [Related]  

  • 7. Norepinephrine dysfunction in depression.
    Anand A; Charney DS
    J Clin Psychiatry; 2000; 61 Suppl 10():16-24. PubMed ID: 10910013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reboxetine: additional benefits to the depressed patient.
    Montgomery SA
    J Psychopharmacol; 1997; 11(4 Suppl):S9-15. PubMed ID: 9438228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. History and evolution of the monoamine hypothesis of depression.
    Hirschfeld RM
    J Clin Psychiatry; 2000; 61 Suppl 6():4-6. PubMed ID: 10775017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chairman's overview. The place of reboxetine in antidepressant therapy.
    Montgomery SA
    J Clin Psychiatry; 1998; 59 Suppl 14():26-9. PubMed ID: 9818628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New antidepressant drug opens up important treatment and safety options.
    Ir Med J; 1996; 89(6):214. PubMed ID: 9011559
    [No Abstract]   [Full Text] [Related]  

  • 12. The selective norepinephrine reuptake inhibitor antidepressant reboxetine: pharmacological and clinical profile.
    Hajós M; Fleishaker JC; Filipiak-Reisner JK; Brown MT; Wong EH
    CNS Drug Rev; 2004; 10(1):23-44. PubMed ID: 14978512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of reboxetine in bulimia nervosa: a pilot study.
    Fassino S; Daga GA; Boggio S; Garzaro L; Pierò A
    J Psychopharmacol; 2004 Sep; 18(3):423-8. PubMed ID: 15358988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Depressed, lacking motivation, unconcentrated. Signs of central deficiency of noradrenaline].
    MMW Fortschr Med; 2004 Jul; 146(27-28):56. PubMed ID: 15526675
    [No Abstract]   [Full Text] [Related]  

  • 15. Reboxetine treatment of depression in Parkinson's disease.
    Lemke MR
    J Clin Psychiatry; 2000 Nov; 61(11):872. PubMed ID: 11105742
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of antidepressants on psychomotor function with particular reference to reboxetine.
    Hindmarch I
    Eur Neuropsychopharmacol; 1997 Apr; 7 Suppl 1():S17-21; discussion S71-3. PubMed ID: 9169307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reboxetine for the treatment of patients with Cocaine Dependence Disorder.
    Szerman N; Peris L; Mesías B; Colis P; Rosa J; Prieto A;
    Hum Psychopharmacol; 2005 Apr; 20(3):189-92. PubMed ID: 15799010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoamine dysfunction and the pathophysiology and treatment of depression.
    Charney DS
    J Clin Psychiatry; 1998; 59 Suppl 14():11-4. PubMed ID: 9818625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noradrenaline in basic models of depression.
    Leonard BE
    Eur Neuropsychopharmacol; 1997 Apr; 7 Suppl 1():S11-6; discussion S71-3. PubMed ID: 9169306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid improvement in affective information processing after acute administration of reboxetine.
    Thase ME
    Am J Psychiatry; 2009 Oct; 166(10):1096-9. PubMed ID: 19797440
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.